RBC Stock UPDATES Regal-Beloit Corp (RBC) 69.68 09/17/2014 1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Regal-Beloit Corp (RBC) 69.68 $RBC

Regal Beloit Corporation Announces Scheduling Change At Morgan Stanley Second Annual Laguna Conference
PR Newswire - Tue Sep 16, 11:18AM CDT
Regal Beloit Corporation (NYSE:RBC) today announced a change in the presentation schedule at the Morgan Stanley Second Annual Laguna Conference on September 16, 2014. Regal Beloit Corporation will now be presenting at 1:35pm PDT (4:35pm EDT).

Health Care REIT Boosts Liquidity; Guides 2H14 Buyouts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 12, 9:50AM CDT
Health Care REIT (HCN) disclosed the common shares offering to strengthen its liquidity position and its projected acquisition pipeline for the second half of 2014.

Regal Beloit Corporation To Present At The Morgan Stanley Second Annual Laguna Conference
PR Newswire - Wed Sep 03, 4:33PM CDT
Regal Beloit Corporation (NYSE:RBC) will be presenting at the Morgan Stanley Second Annual Laguna Conference on September 16, 2014 at 4:30pm PDT.

Insider Trading Alert - APA, RBC And ACHC Traded By Insiders
at The Street - Fri Aug 22, 11:15AM CDT
Stocks with insider trader activity include APA, RBC and ACHC

Downgrade Alert for Regal-Beloit (RBC)
Comtex SmarTrend(R) - Wed Aug 20, 7:55AM CDT
Regal-Beloit (NYSE:RBC) was downgraded from Buy to Neutral at Longbow today. The stock closed yesterday at $71.16 on volume of 198,000 shares, below average daily volume of 317,000. In the past 52 weeks, shares of Regal-Beloit have traded between a low of $62.93 and a high of $80.41 and closed yesterday at $71.16, which is 13% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.6%.

Regal Beloit Corporation To Present At The Jefferies 2014 Global Industrials Conference
PR Newswire - Thu Aug 07, 4:48PM CDT
Regal Beloit Corporation (NYSE:RBC) will be presenting at the Jefferies 2014 Global Industrials Conference August 13, 2014 at 2:00pm EDT.

NYSE stocks posting largest percentage decreases
AP - Thu Jul 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:

NYSE stocks posting largest volume increases
AP - Thu Jul 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:

Regal Beloit Meets Q2 Earnings Estimates, Revenues up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 11:10AM CDT
Regal Beloit (RBC) reported second-quarter 2014 adjusted earnings of $1.27 per share, up 12.4% from $1.13 in the year-ago quarter. Earnings were in line with the Zacks Consensus Estimate.

/C O R R E C T I O N -- Regal Beloit Corporation/
PR Newswire - Tue Jul 29, 7:21PM CDT
In the news release, Regal Beloit Corporation Announces Second Quarter 2014 Financial Results, issued 29-Jul-2014 by Regal Beloit Corporation over PR Newswire, we are advised by the company that the Adjusted Income from Operations table in the Non-GAAP Measures section has changes to the Adjusted Income from Operations line items for both the three and six month periods ended June 28, 2014, as originally issued inadvertently. This correction ONLY impacted the Adjusted Income from Operations table. All other amounts in the original earnings release were correct. The complete, corrected release follows:

Regal Beloit Corporation Announces Second Quarter 2014 Financial Results
PR Newswire - Tue Jul 29, 4:37PM CDT
Regal Beloit Corporation (NYSE: RBC) today reported financial results for the second quarter 2014. Net sales for the second quarter 2014 were $850.4 million compared to $822.0 million for the second quarter 2013. Net income for the second quarter 2014 was $56.2 million compared to $51.1 million for the second quarter 2013. Diluted earnings per share for the second quarter 2014 were $1.24 compared to $1.13 for the second quarter 2013. Adjusted diluted earnings per share were $1.27 for the second quarter 2014 compared to $1.13 for the second quarter 2013.

Regal Beloit announces USD0.22 per share dividend for quarter
M2 - Mon Jul 28, 3:00AM CDT
Chairman and chief executive officer Mark J Gliebe of Regal Beloit Corporation (NYSE:RBC), a manufacturer of electric motors, mechanical and electrical motion controls and power generation products, disclosed on Friday that its board of directors authorised a regular quarterly dividend of USD0.22 per share.

Regal Beloit Declares Dividend
PR Newswire - Fri Jul 25, 5:31PM CDT
Mark J. Gliebe, Chairman and Chief Executive Officer of Regal Beloit Corporation (NYSE: RBC), announced that the Board of Directors, at its regular quarterly meeting held on July 25, 2014, declared a dividend of $.22 per share. The dividend is payable on October 8, 2014, to shareholders of record at the close of business on September 24, 2014. This represents the 217th consecutive dividend declared by the Company.

Macquarie to Fund IMTT Buy With New Debt, Share Issuance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 11, 11:50AM CDT
Macquarie Infrastructure (MIC) announced the pricing of an underwritten public offering of 10 million shares and also of $305 million worth of five-year convertible senior notes, to fund the buyout of International-Matex Tank Terminals.

New Technologies, Appointments, New Contracts, and Conference Call Schedules - Analyst Notes on ExOne, Nordson, B&W, Regal and Hillenbrand
PR Newswire - Thu Jul 03, 5:30AM CDT
Today, Analysts Review released its analysts' notes regarding The ExOne Company (NASDAQ: XONE), Nordson Corporation (NASDAQ: NDSN), The Babcock & Wilcox Company (NYSE: BWC), Regal Beloit Corporation (NYSE: RBC) and Hillenbrand, Inc. (NYSE: HI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4396-100free.

Regal Beloit Acquires Benshaw - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 02, 9:40AM CDT
Regal Beloit Corporation (RBC) recently acquired Benshaw Inc. from Curtiss-Wright Corporation (CW) for $50 million.

Curtiss-Wright Announces Sale of Benshaw Business Unit
GlobeNewswire - Tue Jul 01, 6:30AM CDT
Curtiss-Wright Corporation (NYSE:CW) today announced that it has sold its Benshaw, Inc. (Benshaw) business to Regal-Beloit Corporation (NYSE:RBC) for $50 million in cash.

Regal Beloit Corporation Announces Acquisition of Benshaw, Inc.
PR Newswire - Tue Jul 01, 6:30AM CDT
Regal Beloit Corporation (NYSE: RBC) today announced it has acquired Benshaw Inc., a leader in custom low and medium voltage drives and soft starters, from Curtiss-Wright Corporation (NYSE: CW).

Regal Beloit Corporation To Hold Second Quarter 2014 Earnings Conference Call On Wednesday, July 30, 2014
PR Newswire - Mon Jun 30, 4:05PM CDT
Regal Beloit Corporation (NYSE: RBC) announced today that it plans to release its second quarter 2014 financial results after the market closes on Tuesday, July 29, 2014.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

BioXcel Therapeutics Faces Challenges Amidst 52-Week Low

Updated Category News Views 85

BioXcel Therapeutics: Facing the Heat BioXcel Therapeutics Inc. (BTAI) is in the doghouse—its stock just hit a jaw-dropping 52-week low of $0.53. That's an eye-watering drop of over 80% in the last year. Investors are glued to their screens, weighing whether to grab some shares at rock-bottom prices or steer clear as BioXcel grapples with mounting obstacles. This sharp...

Continue Reading
Guidehouse Welcomes Ron White as New Chief Information Officer

Updated Category News Views 315

Guidehouse Appoints Ron White as Chief Information Officer Advancing the firm's AI-led strategy with visionary leadership to drive business transformation and scalable innovation MCLEAN, Va. – Guidehouse, a global AI-led professional services firm, has recently appointed Ron White as its Chief Information Officer (CIO). With over 35 years of expertise in enterprise...

Continue Reading
Natural Ingredients Driving Growth in Cosmetics Market

Updated Category News Views 186

Market Growth Driven by Consumer Demand Recent studies indicate that the chemicals market for cosmetics and toiletries is experiencing significant growth. The market is set to increase from $27.7 billion to an impressive $35 billion by the end of 2029. This momentum speaks volumes about the trends affecting consumer preferences and the investment patterns of leading...

Continue Reading
Securities Investigation Alert for Semler Scientific Investors

Updated Category News Views 118

Understanding the Semler Scientific Investigation The Rosen Law Firm is actively investigating potential securities claims for investors of Semler Scientific, Inc. (NASDAQ: SMLR). This initiative addresses concerns regarding the possibility that the company may have provided significantly misleading information about its business practices to the public. Why You Should Be...

Continue Reading
Exciting Updates from Bitget Wallet: Join Fomo Thursdays

Updated Category News Views 390

Bitget Wallet Introduces Fomo Thursdays Events Bitget Wallet, a prominent non-custodial crypto wallet, is thrilled to announce the launch of its fourth Fomo Thursdays event, brought to life in collaboration with Velo Protocol. This event focuses on broadening participation in the crypto space, featuring a staggering prize pool of 3.47 million VELO tokens and 50,000 slots...

Continue Reading